Researchers say knowledge about the risks of accelerated aging among women exposed to chemotherapy may help motivate lifestyle changes.

A new hybrid mechanistic-data-driven model of lactate consumption and production for mammalian cell cultures captures both ...

A developer of extracellular vesicle-based products has developed a potency assay suitable for quality control.

Argenx has agreed to acquire Unnatural Products (UNP) for up to $1.15 billion, more than a year after they began partnering ...

Illumina's early access duplex sequencing workflow for MRD and tumor evolution research pairs NovaSeq X with DRAGEN to support the detection of trace ctDNA in plasma.

Discovery offers new insights into the processes that drive cell proliferation and may influence cancer growth, and could ...

The work could lead to new ways of treating pediatric tumors that aim to stop cancer cells from entering states that make them dangerous.

Computer-designed protein therapeutics move from proof-of-concept to wet-lab validation and even clinical trials as the field ...

Next-generation immunotherapy exploits diverse immune populations to address the challenges that CAR T-cell therapy faces.

Nurix Therapeutics suffered its worst one-day loss as a public company Wednesday, nosediving 38% after Sanofi terminated ...

Novartis has confirmed nine instances—seven of them newly disclosed—in which tumors have developed in children treated with its marketed spinal muscular atrophy gene therapy Zolgensma® (onasemnogene ...

Researchers say to their knowledge the study represents the largest study to date of PFAS exposure and breast cancer incidence, particularly for ER-tumors.